mitomycin

Chemotherapy
Feb 14 '19 12:30

In 2016 Dutch cancer patients were treated with medicines of which the active substance came from a rejected Chinese factory, where there was a serious risk of products being contaminated, Zembla reports based on its own research.

Subscribe to